Showing results (1011-1020 of 2,903) with videos related to

Sort By:
Pageof 291
Cancer Gene Therapy|November 1, 2001
Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteinsT Iida, H Kijima, Y Urata, et al.
Cancer Gene Therapy|November 1, 2001
Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growthS BenAmmar-Ceccoli, S Humblot, R Crouzier, et al.
Cancer Gene Therapy|May 16, 2000
Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transferF Candotti, R Agbaria, C A Mullen, et al.
Cancer Gene Therapy|May 16, 2000
A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transferK M Matsuda, S Madoiwa, Y Hasumi, et al.
Cancer Gene Therapy|May 16, 2000
Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cellsM R Veldwijk, S Fruehauf, B Schiedlmeier, et al.
Cancer Gene Therapy|June 1, 2000
Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53L S St John, E R Sauter, M Herlyn, et al.
Cancer Gene Therapy|June 1, 2000
Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectorsD Kunke, D Grimm, S Denger, et al.
Cancer Gene Therapy|June 1, 2000
Cancer gene therapy mediated by CTS1, a p53 derivative: advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2C Bougeret, A Virone-Oddos, E Adeline, et al.
Cancer Gene Therapy|June 1, 2000
Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapyM Hoshi, A Harada, T Kawase, et al.
Cancer Gene Therapy|June 1, 2000
Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapyS Steffens, S Frank, U Fischer, et al.
Pageof 291